Participant flow50

How many started, completed or left each group, period by period.

1 to 20 of 50

Period	Milestone	Group	Participants
Main Study	STARTED	Pegozafermin 9 mg QW	16
Main Study	STARTED	Pegozafermin 18 mg QW	17
Main Study	STARTED	Pegozafermin 27 mg QW	16
Main Study	STARTED	Pegozafermin 36 mg Q2W	16
Main Study	STARTED	Placebo	15
Main Study	Safety Analysis Set	Pegozafermin 9 mg QW	12
Main Study	Safety Analysis Set	Pegozafermin 18 mg QW	21
Main Study	Safety Analysis Set	Pegozafermin 27 mg QW	15
Main Study	Safety Analysis Set	Pegozafermin 36 mg Q2W	16
Main Study	Safety Analysis Set	Placebo	15
Main Study	Full Analysis Set (FAS)	Pegozafermin 9 mg QW	16
Main Study	Full Analysis Set (FAS)	Pegozafermin 18 mg QW	17
Main Study	Full Analysis Set (FAS)	Pegozafermin 27 mg QW	13
Main Study	Full Analysis Set (FAS)	Pegozafermin 36 mg Q2W	16
Main Study	Full Analysis Set (FAS)	Placebo	14
Main Study	COMPLETED	Pegozafermin 9 mg QW	15
Main Study	COMPLETED	Pegozafermin 18 mg QW	16
Main Study	COMPLETED	Pegozafermin 27 mg QW	10
Main Study	COMPLETED	Pegozafermin 36 mg Q2W	15
Main Study	COMPLETED	Placebo	14

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04541186/flow